Joe has been very careful about the insider GNBT s
Post# of 36537
CytoDyn, Inc. (OTC: CYDY)
Class Period: March 27, 2020 – March 9, 2021
Lead Plaintiff Deadline: May 17, 2021
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements touting Leronlimab as a potential treatment for COVID-19 to pump up the CytoDyn’s stock price while executives aggressively sold their shares. The complaint also alleges that CytoDyn engaged in a wrongful scheme whereby Iliad and other Fife entities operated as an unregistered securities dealer for CytoDyn.
There are a lot of S-4s filed during that time period https://www.sec.gov/cgi-bin/browse-edgar?acti...efilings=0
Example: https://www.sec.gov/Archives/edgar/data/11756...ry_doc.xml